Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bernard

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 29, 2026
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)Théo Erard, Gaelle Quéreux, Mona Amini-Adle, et al.
Scientific Reports|March 7, 2019
B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoidNicolas Berkani, Pascal Joly, Marie-Laure Golinski, et al.
JAMA Dermatology|August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in FranceDragos Ciocan, Coralie Barbe, Francois Aubin, et al.
The Journal of Investigative Dermatology|October 15, 2010
Risk factors for bullous pemphigoid in the elderly: a prospective case-control studySylvie Bastuji-Garin, Pascal Joly, Pauline Lemordant, et al.
Archives of Dermatology|May 20, 2009
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort studyPhilippe Bernard, Ziad Reguiai, Emmanuelle Tancrède-Bohin, et al.
JAMA Dermatology|March 8, 2023
Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical TrialPascal Joly, Audrey Lafon, Estelle Houivet, et al.
Blood|January 17, 2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomasFlorent Grange, Tony Petrella, Marie Beylot-Barry, et al.
Archives of Dermatology|March 17, 2010
The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in FranceFrédérique Durbec, Fabien Vitry, Florence Granel-Brocard, et al.
Addiction (Abingdon, England)|April 10, 2024
Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trialHenri-Jean Aubin, Ivan Berlin, Julien Guiraud, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|June 29, 2026
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)Théo Erard, Gaelle Quéreux, Mona Amini-Adle, et al.
Scientific Reports|March 7, 2019
B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoidNicolas Berkani, Pascal Joly, Marie-Laure Golinski, et al.
JAMA Dermatology|August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in FranceDragos Ciocan, Coralie Barbe, Francois Aubin, et al.
The Journal of Investigative Dermatology|October 15, 2010
Risk factors for bullous pemphigoid in the elderly: a prospective case-control studySylvie Bastuji-Garin, Pascal Joly, Pauline Lemordant, et al.
Archives of Dermatology|May 20, 2009
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort studyPhilippe Bernard, Ziad Reguiai, Emmanuelle Tancrède-Bohin, et al.
JAMA Dermatology|March 8, 2023
Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical TrialPascal Joly, Audrey Lafon, Estelle Houivet, et al.
Blood|January 17, 2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomasFlorent Grange, Tony Petrella, Marie Beylot-Barry, et al.
Archives of Dermatology|March 17, 2010
The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in FranceFrédérique Durbec, Fabien Vitry, Florence Granel-Brocard, et al.
Addiction (Abingdon, England)|April 10, 2024
Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trialHenri-Jean Aubin, Ivan Berlin, Julien Guiraud, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
Pageof 14